시장보고서
상품코드
1193068

인공건 및 인공인대 시장 : 용도별(슬관절 손상, 견관절 손상, 발관절 손상, 기타), 최종 사용자별(병원과 진료소, ASC) - 세계 기회 분석 및 산업 예측(2021-2031년)

Artificial Tendons and Ligaments Market By Application (Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries, Others), By End users (Hospitals and Clinics, ASCs): Global Opportunity Analysis and Industry Forecast, 2021-2031

발행일: | 리서치사: Allied Market Research | 페이지 정보: 영문 240 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

인공건 및 인공인대 시장은 2021년에 6430만 달러, 2031년에는 1억 6570만 달러에 이르며 2022년부터 2031년까지 CAGR 10.1%로 성장할 것으로 예측되고 있습니다.

인공 힘줄과 인공 인대는 천연 힘줄과 인대를 보강하거나 교체하기위한 도구이며 필요한 고정 장치도 포함됩니다. 인공 힘줄은 힘줄의 파열과 손상의 치료에도 사용됩니다. 손상 부위는 약하게 느껴지거나 고통스러울 수 있습니다. 힘줄은 근육을 뼈에 연결하는 띠 모양의 부드러운 조직입니다. 인대는 한 뼈와 다른 뼈를 연결하는 섬유질 결합 조직입니다. 근육이 수축하면 힘줄이 뼈를 당겨 관절을 움직일 수 있습니다. 힘줄이 손상되면 움직임이 크게 제한될 수 있습니다. 힘줄 손상에 가장 잘 영향을 받는 관절은 어깨, 팔꿈치, 발목, 허벅지, 무릎 및 손가락입니다. 미국 정형외과학회에 따르면 '저지 핑거'는 힘줄에 영향을 주는 가장 흔한 스포츠 부상 중 하나라고 합니다. 힘줄 손상은 관절의 염증성 질환인 류마티스 관절염의 경우에도 발생합니다. 류마티스 관절염은 힘줄을 감싸고 찢어질 수 있습니다.

손상된 힘줄과 인대는 인공 힘줄과 인대에서 교체하여 치료할 수 있습니다. 인공 힘줄과 인대 교체는 관절에 정상적인 움직임을 되찾기 위해 이루어집니다. 힘줄과 인대 수술은 외과의사가 손상된 힘줄 위의 피부에 하나 이상의 작은 절개(컷)를 하여 손상된 힘줄 또는 인대를 교체하고 힘줄의 끊어진 끝을 함께 꿰매는 것입니다. 그런 다음 주변 조직에서 혈관이나 신경 손상과 같은 다른 손상이 없는지 확인하고 절개부를 닫고 멸균 붕대와 드레싱으로 덮습니다. 수술 후 외과의사는 힘줄이 치유되기를 기다리기 위해 관절을 고정하거나 스프린트 할 것을 제안합니다.

인공건 및 인공인대 시장의 성장을 촉진하는 주요 요인으로는 노인 인구의 증가, 염좌나 긴장, 건염, 타박 등의 스포츠 관련 상해의 증가, 힘줄이나 손목의 상해 발생률의 급증, 아이 그리고 성인의 다른 운동과 신체 활동에 대한 관심의 증가 등을 들 수 있습니다. 예를 들어, 2019년 John Hopkins Medicine의 논문에 따르면, 3천만 명이 조직화된 스포츠에 참여하고 있으며, 염좌나 왜곡으로 인한 스포츠 부상은 미국에서만 연간 350만 명 이상 발생하고 있습니다.

힘줄 손상은 주로 보트 젓기, 무거운 무거운 물건 들어 올리기, 창 닦아, 목공, 일부 조립 라인 작업 등의 직업 활동, 축구, 농구, 페달 사이클, 축구, 아이스 스케이트 및 롤러 스케이트, 스케이트 보드 등 스포츠 활동 등 하드 육체 노동시 발생합니다. 또한 무릎이나 발목, 힘줄을 보강하는 인공근육과 인공건은 침습 수술에 대한 경향이 높아지고, 스포츠 장애에 대한 정부의 계발 활동, 수술 방법의 개발 등에 의해 점점 보급될 것으로 보인다.

게다가 사고가 급증하면 힘줄이나 인대가 손상되고, 특히 교통사고는 인공건과 인공인대 수술 건수의 증가로 이어져 인공건 및 인공인대 시장의 성장에 박차를 가하고 있습니다. 예를 들어 Accident and Emergency(A&E) 통계에 따르면 2019년 스포츠 부상은 2480만 건으로 2018년에 비해 2% 증가하고 있습니다. 게다가, 침습성이 낮은 처치에 대한 수요의 증가는 인공건 및 인공인대제품의 채용을 추진합니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 개요

  • 시장의 정의와 범위
  • 주요 조사 결과
    • 주요 투자 포켓
  • Porter's Five Forces 분석
  • 주요 기업의 포지셔닝
  • 시장 역학
    • 촉진 요인
    • 억제 요인
    • 기회
  • COVID-19 영향 분석

제4장 인공건 및 인공인대 시장 : 용도별

  • 개요
    • 시장 규모 및 예측
  • 무릎 관절 손상
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모 및 예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 어깨 부상
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 발과 발목의 상해
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 기타
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별

제5장 인공건 및 인공인대 시장 : 엔드유저별

  • 개요
    • 시장 규모 및 예측
  • 병원과 클리닉
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • ASC
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별

제6장 인공건 및 인공인대 시장 : 지역별

  • 개요
    • 시장 규모 및 예측
  • 북미
    • 주요 동향과 기회
    • 북미 시장 규모·예측 : 용도별
    • 북미 시장 규모·예측 : 최종 사용자별
    • 북미 시장 규모·예측 : 국가별
      • 미국
      • 캐나다
      • 멕시코
  • 유럽
    • 주요 동향과 기회
    • 유럽 시장 규모·예측 : 용도별
    • 유럽 시장 규모·예측 : 최종 사용자별
    • 유럽 시장 규모·예측 : 국가별
      • 독일
      • 프랑스
      • 영국
      • 이탈리아
      • 스페인
      • 기타 유럽
  • 아시아태평양
    • 주요 동향과 기회
    • 아시아태평양의 시장 규모·예측 : 용도별
    • 아시아태평양의 시장 규모·예측 : 최종 사용자별
    • 아시아태평양의 시장 규모·예측 : 국가별
      • 일본
      • 중국
      • 인도
      • 호주
      • 한국
      • 기타 아시아태평양
  • LAMEA
    • 주요 동향과 기회
    • LAMEA의 시장 규모·예측 : 용도별
    • LAMEA의 시장 규모·예측 : 엔드유저별
    • LAMEA의 시장 규모·예측 : 국가별
      • 브라질
      • 남아프리카 공화국
      • 사우디아라비아
      • 기타 LAMEA 지역

제7장 기업 정세

  • 소개
  • 주요 성공 전략
  • 주요 10개사의 제품 매핑
  • 경쟁 대시보드
  • 경쟁 히트맵
  • 주요 발전

제8장 기업 프로필

  • Arthrex, Inc.
  • fx solutions
  • Orthomed SAS
  • Neoligaments
  • Artelon
  • Corin Groups
  • Mathys AG
  • FH Orthopedics
  • Integra Lifesciences Corporation
  • Stryker Corporation
ksm 23.03.27

The artificial tendons and ligaments market was valued at $64.3 million in 2021 and is estimated to reach $165.7 million by 2031, growing at a CAGR of 10.1% from 2022 to 2031.

Artificial tendons and ligament tools intended to reinforce or replace natural tendons, and ligaments, including any necessary fixing devices. Artificial tendons are also used to treat torn and damaged tendons. The damaged area may feel weak or painful. Tendons are soft, band-like tissues that connect muscles to bone. Ligaments are fibrous connective tissue that connects one bone to another bone. When the muscles contract, the tendons pull the bones and cause the joints to move. When tendon damage occurs, movement may be seriously limited. The joints that are most commonly affected by tendon injuries are the shoulders, elbows, ankles, thighs, knees, and fingers. According to the American Academy of Orthopedic Surgeons, "jersey finger" is one of the most common sports injuries affecting the tendons. Tendon damage can also occur in rheumatoid arthritis, an inflammatory disease of the joints. Rheumatoid arthritis can involve the tendons, causing them to tear.

The damaged tendon and ligaments can be treated by replacement from artificial tendons and ligaments. The replacement of artificial tendons and ligaments is done to bring back normal movement to a joint. In tendons and ligament surgery, a surgeon will make one or more small incisions (cuts) in the skin over the damaged tendon, replace the damaged tendon or ligament, and sew the torn ends of the tendon together. After, check the surrounding tissue to make sure no other injuries, such as injury to the blood vessels or nerves have occurred, and then close the incision and cover the area with sterile bandages or dressings. After surgery, the surgeon will suggest immobilizing or splinting the joint to allow the tendon to heal.

Major factors driving the growth of the artificial tendons and ligaments market include an increase in the geriatric population, a rise in sports-related injuries such as sprains, strains, tendinitis, and contusions, the surge in incidences of tendon and wrist injuries, and an increase in interest in other workouts and physical activities among children and adults. For instance, according to a John Hopkins Medicine article in 2019, 30 million individuals participate in organized sports, resulting in more than 3.5 million sports injuries annually in the U.S. alone, with sprains and strains.

Tendon injury mostly occurs during hard physical work out such as rowing, heavy weight lifting, occupation activities such as window washing, woodwork, some assembly line works, and sports activities such as football, basketball, pedal cycling, soccer, ice or roller skating, and skateboarding. Artificial muscles and tendons for knee, ankle, and tendon reinforcement will also become increasingly popular due to a growing propensity for minimally invasive procedures, government activities to raise awareness about sports injuries, and developments in surgical methods.

Moreover, the surge in accidents causes tendons and ligament damage, particularly road accidents leading to an increase in the number of artificial tendons and ligament surgeries, thus fueling the growth of the artificial tendons and ligament market. For instance, according to Accident and Emergency (A&E) statistics, 24.8 million sports injuries were recorded in 2019, an increase of 2% compared with 2018. Furthermore, an increase in demand for minimally invasive procedures propels the adoption of artificial tendons and ligaments product.

In addition, technological advancements; the launch of various products; strategies among key players such as acquisition, collaboration, and agreement drive the growth of the artificial tendons and ligaments market

For instance, in 2021, Striker launched its Citrelock tendon fixation devices system for orthopedic surgical applications. The new system provides surgeons with a differentiated design via a tendon thread featuring a resorbable technology, known as Citregen, which has unique chemical and mechanical properties for orthopedic surgical applications. The launch of Citrelock will help the company to strengthen its orthopedics portfolio.

However, the lack of acceptance for biological products and the lack of appropriate knowledge regarding products among physicians and surgeons limit the market growth. Stricter regulatory standards and high costs for artificial tendons and ligament products also restrain market growth. Furthermore, the healthcare business is predicted to witness growth, owing to a rise in the prevalence of tendonitis and obesity, an increase in R&D investments in drug discovery & development, and a rise in awareness regarding physical fitness and workout. This is anticipated to offer remunerative opportunities for key players to invest in the market during the forecast period.

The artificial tendons and ligaments market is segmented on the basis of application, end user, and region. On the basis of application, the market is classified into knee Injuries, Shoulder Injuries, foot and ankle injuries, and others. Depending on the end user, it is segmented into hospitals and clinics, and ambulatory surgery centers. The artificial tendons and ligaments market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

Major players profiled in the report are Artelon, Arthrex, Inc., Corin Group, Enovis, Exactech, Inc., FX-Global Inc., Group FH Communication, Integra Lifesciences, Neoligaments, Stryker Corporation.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the artificial tendons and ligaments market analysis from 2021 to 2031 to identify the prevailing artificial tendons and ligaments market opportunities.

Market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.

An in-depth analysis of the artificial tendons and ligaments market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes analysis of the regional as well as global artificial tendons and ligaments market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Application

  • Foot and Ankle Injuries
  • Knee Injuries
  • Shoulder Injuries
  • Others

By End users

  • Hospitals and Clinics
  • ASCs

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA
  • Key Market Players
    • Arthrex, Inc.
    • fx solutions
    • Orthomed S.A.S
    • Neoligaments
    • Artelon
    • Corin Groups
    • Mathys AG
    • F H Orthopedics
    • Integra Lifesciences Corporation
    • Stryker Corporation

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Knee Injuries
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3 Shoulder Injuries
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country
  • 4.4 Foot and Ankle Injuries
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market share analysis by country
  • 4.5 Others
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market share analysis by country

CHAPTER 5: ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Hospitals and Clinics
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3 ASCs
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country

CHAPTER 6: ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY REGION

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 North America
    • 6.2.1 Key trends and opportunities
    • 6.2.2 North America Market size and forecast, by Application
    • 6.2.3 North America Market size and forecast, by End users
    • 6.2.4 North America Market size and forecast, by country
      • 6.2.4.1 U.S.
      • 6.2.4.1.1 Key market trends, growth factors and opportunities
      • 6.2.4.1.2 Market size and forecast, by Application
      • 6.2.4.1.3 Market size and forecast, by End users
      • 6.2.4.2 Canada
      • 6.2.4.2.1 Key market trends, growth factors and opportunities
      • 6.2.4.2.2 Market size and forecast, by Application
      • 6.2.4.2.3 Market size and forecast, by End users
      • 6.2.4.3 Mexico
      • 6.2.4.3.1 Key market trends, growth factors and opportunities
      • 6.2.4.3.2 Market size and forecast, by Application
      • 6.2.4.3.3 Market size and forecast, by End users
  • 6.3 Europe
    • 6.3.1 Key trends and opportunities
    • 6.3.2 Europe Market size and forecast, by Application
    • 6.3.3 Europe Market size and forecast, by End users
    • 6.3.4 Europe Market size and forecast, by country
      • 6.3.4.1 Germany
      • 6.3.4.1.1 Key market trends, growth factors and opportunities
      • 6.3.4.1.2 Market size and forecast, by Application
      • 6.3.4.1.3 Market size and forecast, by End users
      • 6.3.4.2 France
      • 6.3.4.2.1 Key market trends, growth factors and opportunities
      • 6.3.4.2.2 Market size and forecast, by Application
      • 6.3.4.2.3 Market size and forecast, by End users
      • 6.3.4.3 UK
      • 6.3.4.3.1 Key market trends, growth factors and opportunities
      • 6.3.4.3.2 Market size and forecast, by Application
      • 6.3.4.3.3 Market size and forecast, by End users
      • 6.3.4.4 Italy
      • 6.3.4.4.1 Key market trends, growth factors and opportunities
      • 6.3.4.4.2 Market size and forecast, by Application
      • 6.3.4.4.3 Market size and forecast, by End users
      • 6.3.4.5 Spain
      • 6.3.4.5.1 Key market trends, growth factors and opportunities
      • 6.3.4.5.2 Market size and forecast, by Application
      • 6.3.4.5.3 Market size and forecast, by End users
      • 6.3.4.6 Rest of Europe
      • 6.3.4.6.1 Key market trends, growth factors and opportunities
      • 6.3.4.6.2 Market size and forecast, by Application
      • 6.3.4.6.3 Market size and forecast, by End users
  • 6.4 Asia-Pacific
    • 6.4.1 Key trends and opportunities
    • 6.4.2 Asia-Pacific Market size and forecast, by Application
    • 6.4.3 Asia-Pacific Market size and forecast, by End users
    • 6.4.4 Asia-Pacific Market size and forecast, by country
      • 6.4.4.1 Japan
      • 6.4.4.1.1 Key market trends, growth factors and opportunities
      • 6.4.4.1.2 Market size and forecast, by Application
      • 6.4.4.1.3 Market size and forecast, by End users
      • 6.4.4.2 China
      • 6.4.4.2.1 Key market trends, growth factors and opportunities
      • 6.4.4.2.2 Market size and forecast, by Application
      • 6.4.4.2.3 Market size and forecast, by End users
      • 6.4.4.3 India
      • 6.4.4.3.1 Key market trends, growth factors and opportunities
      • 6.4.4.3.2 Market size and forecast, by Application
      • 6.4.4.3.3 Market size and forecast, by End users
      • 6.4.4.4 Australia
      • 6.4.4.4.1 Key market trends, growth factors and opportunities
      • 6.4.4.4.2 Market size and forecast, by Application
      • 6.4.4.4.3 Market size and forecast, by End users
      • 6.4.4.5 South Korea
      • 6.4.4.5.1 Key market trends, growth factors and opportunities
      • 6.4.4.5.2 Market size and forecast, by Application
      • 6.4.4.5.3 Market size and forecast, by End users
      • 6.4.4.6 Rest of Asia-Pacific
      • 6.4.4.6.1 Key market trends, growth factors and opportunities
      • 6.4.4.6.2 Market size and forecast, by Application
      • 6.4.4.6.3 Market size and forecast, by End users
  • 6.5 LAMEA
    • 6.5.1 Key trends and opportunities
    • 6.5.2 LAMEA Market size and forecast, by Application
    • 6.5.3 LAMEA Market size and forecast, by End users
    • 6.5.4 LAMEA Market size and forecast, by country
      • 6.5.4.1 Brazil
      • 6.5.4.1.1 Key market trends, growth factors and opportunities
      • 6.5.4.1.2 Market size and forecast, by Application
      • 6.5.4.1.3 Market size and forecast, by End users
      • 6.5.4.2 South Africa
      • 6.5.4.2.1 Key market trends, growth factors and opportunities
      • 6.5.4.2.2 Market size and forecast, by Application
      • 6.5.4.2.3 Market size and forecast, by End users
      • 6.5.4.3 Saudi Arabia
      • 6.5.4.3.1 Key market trends, growth factors and opportunities
      • 6.5.4.3.2 Market size and forecast, by Application
      • 6.5.4.3.3 Market size and forecast, by End users
      • 6.5.4.4 Rest of LAMEA
      • 6.5.4.4.1 Key market trends, growth factors and opportunities
      • 6.5.4.4.2 Market size and forecast, by Application
      • 6.5.4.4.3 Market size and forecast, by End users

CHAPTER 7: COMPANY LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Key developments

CHAPTER 8: COMPANY PROFILES

  • 8.1 Arthrex, Inc.
    • 8.1.1 Company overview
    • 8.1.2 Company snapshot
    • 8.1.3 Operating business segments
    • 8.1.4 Product portfolio
    • 8.1.5 Business performance
    • 8.1.6 Key strategic moves and developments
  • 8.2 fx solutions
    • 8.2.1 Company overview
    • 8.2.2 Company snapshot
    • 8.2.3 Operating business segments
    • 8.2.4 Product portfolio
    • 8.2.5 Business performance
    • 8.2.6 Key strategic moves and developments
  • 8.3 Orthomed S.A.S
    • 8.3.1 Company overview
    • 8.3.2 Company snapshot
    • 8.3.3 Operating business segments
    • 8.3.4 Product portfolio
    • 8.3.5 Business performance
    • 8.3.6 Key strategic moves and developments
  • 8.4 Neoligaments
    • 8.4.1 Company overview
    • 8.4.2 Company snapshot
    • 8.4.3 Operating business segments
    • 8.4.4 Product portfolio
    • 8.4.5 Business performance
    • 8.4.6 Key strategic moves and developments
  • 8.5 Artelon
    • 8.5.1 Company overview
    • 8.5.2 Company snapshot
    • 8.5.3 Operating business segments
    • 8.5.4 Product portfolio
    • 8.5.5 Business performance
    • 8.5.6 Key strategic moves and developments
  • 8.6 Corin Groups
    • 8.6.1 Company overview
    • 8.6.2 Company snapshot
    • 8.6.3 Operating business segments
    • 8.6.4 Product portfolio
    • 8.6.5 Business performance
    • 8.6.6 Key strategic moves and developments
  • 8.7 Mathys AG
    • 8.7.1 Company overview
    • 8.7.2 Company snapshot
    • 8.7.3 Operating business segments
    • 8.7.4 Product portfolio
    • 8.7.5 Business performance
    • 8.7.6 Key strategic moves and developments
  • 8.8 F H Orthopedics
    • 8.8.1 Company overview
    • 8.8.2 Company snapshot
    • 8.8.3 Operating business segments
    • 8.8.4 Product portfolio
    • 8.8.5 Business performance
    • 8.8.6 Key strategic moves and developments
  • 8.9 Integra Lifesciences Corporation
    • 8.9.1 Company overview
    • 8.9.2 Company snapshot
    • 8.9.3 Operating business segments
    • 8.9.4 Product portfolio
    • 8.9.5 Business performance
    • 8.9.6 Key strategic moves and developments
  • 8.10 Stryker Corporation
    • 8.10.1 Company overview
    • 8.10.2 Company snapshot
    • 8.10.3 Operating business segments
    • 8.10.4 Product portfolio
    • 8.10.5 Business performance
    • 8.10.6 Key strategic moves and developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제